Acrivon Therapeutics, Inc. Common Stock Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ADAG
|
Adagene Inc. | $2.34 | $131.46 M | -6.77 | 174 | $18.11 M |
 ANAB
|
AnaptysBio, Inc. | $21.38 | $640.07 M | -3.82 | 117 | $17.16 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.51 | $56.28 M | -5.86 | 2 | $0 |
 ANTX
|
AN2 Therapeutics, Inc. | $1.29 | $60.55 M | -0.81 | 41 | $0 |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.60 | $597.48 M | -6.84 | 51 | $0 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.01 | $652.38 M | -6.03 | 28 | $0 |
 MOLN
|
Molecular Partners AG | $5.34 | $135.05 M | -2.03 | 167 | $7.04 M |
 OPT
|
Opthea Limited | $3.23 | $214.34 M | -1.04 | 33 | $261,859 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.62 | $85.40 M | -1.26 | 63 | $0 |
 RZLT
|
Rezolute, Inc. | $4.85 | $229.57 M | -5.02 | 59 | $0 |